Global AI in Telemedicine Market 2024 - 2031

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	196 Pages	DataM Intelligence 4Market Research LLP	February, 2025	DTAM19614100

Best Price Guarantee
Price	from $4,350
Length	196 Pages
Publisher	DataM Intelligence 4Market Research LLP
Published Date	February, 2025
SKU	DTAM19614100

Global AI in Telemedicine Market reached US$ 14.8 billion in 2023 and is expected to reach US$ 91.8 billion by 2031, growing at a CAGR of 26.7% during the forecast period 2024-2031.

AI in telemedicine a wide range of new options for both healthcare providers and patients. AI improves telemedicine by enhancing diagnostic accuracy, enabling remote patient monitoring, analyzing medical images, providing virtual triage or medical consulting services, and more. It boosts the efficiency, accessibility, and quality of telemedicine services.

It empowers healthcare providers with data-driven insights and decision-making capabilities, enabling them to deliver more efficient and personalized care. It also enables tailored treatment plans based on individual patient characteristics, leading to better outcomes.

Market Dynamics: Drivers & Restraints

Advancements in AI Technology

Rising advancements in AI technology are expected to be a significant driving factor for market growth. The enhanced diagnostic applications and capabilities that can analyze medical data more quickly and accurately than traditional methods are expected to adopt AI in telemedicine.4

For instance, on September 27, 2023, HealthTap launched a new version of its Dr.A.I. feature, a pre-appointment patient interview experience powered by GPT-4. The most advanced ChatGPT system from OpenAI, GPT-4 is an artificial intelligence language model capable of human-like conversation. Dr.A.I.

For instance, in June 2024, C3 Med-Tech secured an undisclosed amount from Industrial Metal Powders to launch new telemedicine and artificial intelligence (AI)-enabled portable equipment for smooth and quick eye checkups and detecting eye diseases in real-time. Thus, the increasing technological advancements are expected to drive the market growth.

High Expenses

Implementing AI-enabled telemedicine can be costly, especially in circumstances where financial resources are only a few. The expenses of building and maintaining the technology and infrastructure, as well as training and compensating employees, can be huge. Thus, the above factors could restrain the market growth.

Market Segment Analysis

The global AI in telemedicine market is segmented based on product, process, application and region.

The data analysis segment is expected to dominate the market share

AI utilizes previous information to predict patient outcomes and possible health risks, allowing for preventative interventions and better resource allocation. Data analysis can help to optimize workflow and resource management in telemedicine systems, lowering costs and enhancing service delivery.

Telemedicine platforms can personalize treatment programs for individuals based on their medical history, genetics, and lifestyle, resulting in better outcomes. AI-powered data analysis helps healthcare providers make better decisions by analyzing large volumes of patient data, recognizing trends, and providing insights into patient care.

Market Geographical Share

North America is expected to hold a significant position in the AI in telemedicine market share

The region has a well-established technological infrastructure that allows the development and implementation of AI solutions in healthcare. Healthcare professionals and patients are increasingly accepting and integrating telemedicine technology, which has been accelerated by the COVID-19 epidemic.

North America has a wealth of healthcare data, which is essential for training AI models and improving their accuracy in diagnosing and treating patients. Many healthcare institutions are creating partnerships with technology companies to create and improve AI-powered telemedicine solutions, hence increasing market growth.

Market Segmentation

By Product
• Software
• Services

By Process
• Data Analysis
• Image Recognition
• Natural Language Processing
• Virtual Consultations

By Application
• Virtual Health Assistants and Chatbots
• Remote Monitoring and Predictive Analysis
• Diagnostics and Medical Imaging
• Medication Adherence and Treatment Plans
• Teleconsultation Enhancement
• Others

By Region
• North America
The U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Market Companies

The major global players in the market include Intel Corporation, Chetu Inc., TiaTech Health Technologies, ValueCoders, LeewayHertz, Vonage Holdings Corp., Caption Health, Inc., Corti HQ, Biobeat Technologies, and Owkin, Inc. among others.

Why Purchase the Report?
• To visualize the global AI in telemedicine market segmentation based on product, process, application, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of AI in telemedicine market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global AI in telemedicine market report would provide approximately 53 tables, 47 figures and 176 pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope: 1.1. Research Methodology; 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary: 3.1. Snippet by Product; 3.2. Snippet by Process; 3.3. Snippet by Application; 3.4. Snippet by Region
4. Dynamics: 4.1. Impacting Factors; 4.1.1. Drivers; 4.1.1.1. Advancements in AI Technology; 4.1.1.2. XX; 4.1.2. Restraints; 4.1.2.1. In High Expenses; 4.1.2.2. XX; 4.1.3. Opportunity; 4.1.4. Impact Analysis
5. Industry Analysis: 5.1. Porter's Five Force Analysis; 5.2. Supply Chain Analysis; 5.3. Pricing Analysis; 5.4. Regulatory Analysis; 5.5. Reimbursement Analysis; 5.6. Patent Analysis; 5.7. SWOT Analysis; 5.8. DMI Opinion
6. By Product: 6.1. Introduction; 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 6.1.2. Market Attractiveness Index, By Product; 6.2. Software*; 6.2.1. Introduction; 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 6.3. Services
7. By Process: 7.1. Introduction; 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process; 7.1.2. Market Attractiveness Index, By Process; 7.2. Data Analysis*; 7.2.1. Introduction; 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 7.3. Image Recognition; 7.4. Natural Language Processing; 7.5. Virtual Consultations
8. By Application: 8.1. Introduction; 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 8.1.2. Market Attractiveness Index, By Application; 8.2. Virtual Health Assistants and Chatbots*; 8.2.1. Introduction; 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 8.3. Remote Monitoring and Predictive Analysis; 8.4. Diagnostics and Medical Imaging; 8.5. Medication Adherence and Treatment Plans; 8.6. Teleconsultation Enhancement; 8.7. Others
9. By Region: 9.1. Introduction; 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region; 9.1.2. Market Attractiveness Index, By Region; 9.2. North America; 9.2.1. Introduction; 9.2.2. Key Region-Specific Dynamics; 9.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 9.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process; 9.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.2.3.1. U.S.; 9.2.3.2. Canada; 9.2.3.3. Mexico; 9.3. Europe; 9.3.1. Introduction; 9.3.2. Key Region-Specific Dynamics; 9.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 9.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process; 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.3.4.1. Germany; 9.3.4.2. UK; 9.3.4.3. France; 9.3.4.4. Italy; 9.3.4.5. Spain; 9.3.4.6. Rest of Europe; 9.4. South America; 9.4.1. Introduction; 9.4.2. Key Region-Specific Dynamics; 9.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 9.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process; 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.4.4.1. Brazil; 9.4.4.2. Argentina; 9.4.4.3. Rest of South America; 9.5. Asia-Pacific; 9.5.1. Introduction; 9.5.2. Key Region-Specific Dynamics; 9.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 9.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process; 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.5.4.1. China; 9.5.4.2. India; 9.5.4.3. Japan; 9.5.4.4. Australia; 9.5.4.5. Rest of Asia-Pacific; 9.6. Middle East and Africa; 9.6.1. Introduction; 9.6.2. Key Region-Specific Dynamics; 9.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product; 9.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process; 9.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape: 10.1. Competitive Scenario; 10.2. Market Positioning/Share Analysis; 10.3. Mergers and Acquisitions Analysis
11. Company Profiles: 11.1. Intel Corporation*; 11.1.1. Company Overview; 11.1.2. Product Portfolio and Description; 11.1.3. Financial Overview; 11.1.4. Key Developments; 11.2. Chetu Inc.; 11.3. TiaTech Health Technologies; 11.4. ValueCoders; 11.5. LeewayHertz; 11.6. Vonage Holdings Corp.; 11.7. Caption Health, Inc.; 11.8. Corti HQ; 11.9. Biobeat Technologies; 11.10. Owkin, Inc (*LIST NOT EXHAUSTIVE)
12. Appendix: 12.1. About Us and Services; 12.2. Contact Us